In contrast to the high expression levels of death receptors on GBM cells in response to Olaparib treatment, the expression levels of their corresponding ligands, TRAIL and FasL, on NK cells were relatively low and were unaffected by Olaparib treatment and co-culture with T98G cells. This evidence concerns the gene FASLG and glioblastoma.